文献速递心律失常心力衰竭与心肌病

植入式心律转复除颤器在致心律失常性右心室心肌病患者中的事件分析

Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
PubMed 文献 · Heart · 2021-03-04

该单中心长期观察纳入65例确诊致心律失常性右心室心肌病(ARVC)并植入ICD的成人患者,中位随访7.75年。结果显示66.2%发生适当ICD干预,27.7%发生不适当干预;右心室功能障碍、植入时年龄<40岁及持续性室性心动过速病史是适当ICD干预的预测因素。

要点

  • ARVC患者ICD适当干预率较高,需重视风险分层。
  • 右心室功能障碍、年龄<40岁、持续性室速病史预测适当干预。
  • 不适当ICD干预预测因素未明确,需个体化随访。

核心结论

  • 右心室功能障碍、植入时年龄<40岁和持续性室性心动过速病史是ARVC患者适当ICD干预的预测因素。
  • 研究结果可用于改进ICD植入前的风险分层。

研究设计与样本

  • 长期单中心观察性研究,纳入65例确诊ARVC并接受ICD的成人患者(中位年龄40岁,48例男性)。
  • ICD用于心脏性猝死一级预防占40%,二级预防占60%,植入时间跨度20年。
  • 研究终点为植入后首次适当和不适当ICD干预(电击或抗心动过速起搏)。

主要发现

  • 中位随访7.75年,9例死亡,6例接受心脏移植。
  • 43例(66.2%)发生适当ICD干预,18例(27.7%)发生不适当ICD干预。
  • 多变量分析显示右心室功能障碍(原因特异性HR 2.85,95%CI 1.56-5.21,p<0.001)、植入时年龄<40岁(HR 2.37,95%CI 1.13-4.94,p=0.022)和持续性室速病史(HR 2.55,95%CI 1.16-5.63,p=0.020)预测适当ICD干预。
  • 未发现不适当ICD治疗的预测因素。
  • 12例患者发生ICD植入相关并发症。

临床怎么用

  • 对于ARVC患者,植入ICD前应评估右心室功能、年龄及持续性室速病史以优化风险分层。
  • ICD植入后需关注适当与不适当干预,并警惕植入相关并发症。

局限性

  • 单中心观察性研究,样本量较小(65例),结果需外部验证。
  • 未发现不适当ICD干预的预测因素,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a risk of sudden cardiac death. Optimal risk stratification is still under debate. The main purpose of this long-term, single-centre observation was to analyse predictors of appropriate and inappropriate implantable cardioverter-defibrillator (ICD) interventions in the population of patients with ARVC with a high risk of life-threatening arrhythmias. METHODS: The study comprised 65 adult patients (median age 40 years, 48 men) with a definite diagnosis of ARVC who received ICD over a time span of 20 years in primary (40%) or secondary (60%) prevention of sudden cardiac death. The study endpoints were first appropriate and inappropriate ICD interventions (shock or antitachycardia pacing) after device implantation. RESULTS: During a median follow-up of 7.75 years after ICD implantation, nine patients died and six individuals underwent heart transplantation. Appropriate ICD interventions occurred in 43 patients (66.2%) and inappropriate ICD interventions in 18 patients (27.7%). Multivariable analysis using cause-specific hazard model identified three predictors of appropriate ICD interventions: right ventricle dysfunction (cause-specific HR 2.85, 95% CI 1.56 to 5.21, p<0.001), age <40 years at ICD implantation (cause-specific HR 2.37, 95% CI 1.13 to 4.94, p=0.022) and a history of sustained ventricular tachycardia (cause-specific HR 2.55, 95% CI 1.16 to 5.63, p=0.020). Predictors of inappropriate ICD therapy were not found. Complications related to ICD implantation occurred in 12 patients. CONCLUSIONS: Right ventricle dysfunction, age <40 years and a history of sustained ventricular tachycardia were predictors of appropriate ICD interventions in patients with ARVC. The results may be used to improve risk stratification before ICD implantation.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Woźniak O, Borowiec K, Konka M, et al. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy. Heart. 2021. PMID: 33674353. doi:10.1136/heartjnl-2020-318415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。